FASLODEX
NDC 0310-0720, Fulvestrant, injection, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-0720
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021344
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-0720-10 | 00310072010 | 2 SYRINGE, GLASS in 1 CARTON (0310-0720-10) / 5 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/83d7a440-e904-4e36-afb5-cb02b1c919f7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0310-0720
Use it
Look up 0310-0720 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-0720. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.